United Kingdom

Public Health England: AstraZeneca COVID shot 94% protective against death in over 65s

2 minute read

A vial of AstraZeneca coronavirus vaccine is seen at a vaccination centre in Westfield Stratford City shopping centre, amid the outbreak of coronavirus disease (COVID-19), in London, Britain, February 18, 2021. REUTERS/Henry Nicholls//File Photo

LONDON, July 1 (Reuters) - Two doses of the Oxford/AstraZeneca (AZN.L) COVID-19 vaccine gives an estimated 94% protection against death from the disease in people over 65, Public Health England said on Thursday in a weekly surveillance report of real-world data.

PHE said the majority of the data was derived from a period when the Alpha variant, first detected in England, was still dominant and did not provide a specific estimate of protection from death that the vaccine offered against the now more widespread Delta variant, first detected in India.

PHE also said that for the under 40s, early estimates suggested a single dose of Pfizer's (PFE.N) vaccine is 61% effective against symptomatic disease and a single dose of the Moderna (MRNA.O) vaccine is 72% effective.

"This data gives us even more confidence that the vaccines offer high levels of protection against COVID-19 across all age groups," said Jamie Lopez Bernal, consultant epidemiologist at PHE.

Register now for FREE unlimited access to reuters.com
Reporting by Alistair Smout; Editing by Kate Holton and William Schomberg

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters